Intervention 1: Clinical Trials

4 trials of Intervention 1, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 not yet recruiting, 1 recruiting, 1 withdrawn. 4 Phase 2, 2 Phase 3, 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 24Completed 1, Not yet recruiting 1, Recruiting 1, Withdrawn 1
Phase 32Not yet recruiting 1, Recruiting 1
Phase 11Withdrawn 1

Follow Intervention 1: new trials by email Literature Review of Intervention 1 trials Research Report on Intervention 1

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Oxfendazole in Mild Parenchymal Brain Cysticercosis
Oxfendazole single dose, Oxfendazole three doses, albendazole plus praziquantel regime - Brain Cysticercosis
Phase 2 / Phase 3Not yet recruitingUniversidad Peruana Cayetano Heredia5442026-12-012026-05-01
The Use of Melatonin for Delirium Prevention in Medically Hospitalized Patients
Intervention 1, Intervention 2, Control - Delirium
Phase 2 / Phase 3RecruitingSultan Qaboos University2402024-09-302025-01-14
A Study of ORTD-1 in Patients Hospitalized With COVID-19 Related Pneumonia
ORTD-1 low dose, ORTD-1 mid dose, ORTD-1 high dose - COVID-19
Phase 1 / Phase 2WithdrawnOryn Therapeutics, LLC2021-04-012021-06-14
Randomized Trial of Liposomal Amphotericin B for Histoplasmosis in AIDS Patients
single dose of L-AmB, 2 doses of L-AmB, 2 weeks of L-AmB - Histoplasmosis, AIDS
Phase 2CompletedAlessandro Pasqualotto1182020-02-142025-03-14

Conditions studied

Acquired Immunodeficiency Syndrome (1)  ·  COVID-19 (1)  ·  Cysticercosis (1)  ·  Delirium (1)  ·  Histoplasmosis (1)  ·  Neurocysticercosis (1)

Sponsors

Alessandro Pasqualotto (1)  ·  Oryn Therapeutics, LLC (1)  ·  Sultan Qaboos University (1)  ·  Universidad Peruana Cayetano Heredia (1)

Countries

Brazil (1)  ·  Oman (1)  ·  United States (1)

Top investigators

Alpesh Amin, MD (1)  ·  Daiane Dalla Lana, PhD (1)  ·  Hector H Garcia, MD, PhD (1)

Results publications

PMID 40000080, PMID 41592826